Literature DB >> 1819728

Significance of platelet-activating factor in mesenteric ischemia-reperfusion.

J Filep1, P Braquet, T Mózes.   

Abstract

Reperfusion of the ischemic mesenterium is frequently followed by acute circulatory collapse. This review focuses on the possible role of platelet-activating factor (PAF) in ischemia-induced damage. It provides evidence that (i) PAF concentrations are elevated in the mesenteric circulation following temporary ischemia; (ii) administration of exogenous PAF into the superior mesenteric vein mimics many events observed during reperfusion; and (iii) pretreatment of the experimental animals with specific PAF receptor antagonists prevent the circulatory collapse. These findings suggest that PAF may play an important role in the development of circulatory collapse caused by mesenteric ischemia-reperfusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819728     DOI: 10.1007/BF02536561

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  43 in total

1.  Significance of lipid mediators in shock states.

Authors:  A M Lefer
Journal:  Circ Shock       Date:  1989-01

2.  Platelet activating factor antagonism with BN52021 protects the kidney against acute ischemic injury.

Authors:  G E Plante; P Sirois; P Braquet
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1988-10       Impact factor: 4.006

3.  Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs.

Authors:  P Bessin; J Bonnet; D Apffel; C Soulard; L Desgroux; I Pelas; J Benveniste
Journal:  Eur J Pharmacol       Date:  1983-01-21       Impact factor: 4.432

4.  Glomeruli from ischemic rat kidneys produce increased amounts of platelet activating factor.

Authors:  A López-Farré; M Torralbo; J M López-Novoa
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

5.  Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

Authors:  T W Doebber; M S Wu; J C Robbins; B M Choy; M N Chang; T Y Shen
Journal:  Biochem Biophys Res Commun       Date:  1985-03-29       Impact factor: 3.575

6.  Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver.

Authors:  C Caramelo; S Fernández-Gallardo; J C Santos; P Iñarrea; M Sánchez-Crespo; J M López-Novoa; L Hernando
Journal:  Eur J Clin Invest       Date:  1987-02       Impact factor: 4.686

7.  Experimental cerebral ischemia produces platelet aggregates.

Authors:  J H Dougherty; D E Levy; B B Weksler
Journal:  Neurology       Date:  1979-11       Impact factor: 9.910

8.  Cerebral blood flow and oxygen uptake in endotoxic shock. An experimental study in dogs.

Authors:  B Ekström-Jodal; E Häggendal; L E Larsson
Journal:  Acta Anaesthesiol Scand       Date:  1982-06       Impact factor: 2.105

9.  Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia.

Authors:  G L Stahl; Z Terashita; A M Lefer
Journal:  J Pharmacol Exp Ther       Date:  1988-03       Impact factor: 4.030

Review 10.  Is there a case for PAF antagonists in the treatment of ischemic states?

Authors:  P Braquet; M Paubert-Braquet; M Koltai; R Bourgain; F Bussolino; D Hosford
Journal:  Trends Pharmacol Sci       Date:  1989-01       Impact factor: 14.819

View more
  2 in total

1.  Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.

Authors:  J G Filep; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

2.  Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX-1 and COX-2 selective inhibitors, and an LTC4 receptor antagonist.

Authors:  Thiruma V Arumugam; Naomi Arnold; Lavinia M Proctor; Michelle Newman; Robert C Reid; Karl A Hansford; David P Fairlie; Ian A Shiels; Stephen M Taylor
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.